Announced
Completed
NOVEL LABORATORIES INC. / GAVIS PHARMACEUTICALS LLC / LUPIN LIMITED / Private / Acquisition / £564m
Financials
Transaction Value£564m
Consideration Type-
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.